Abbott recently launched a smartphone app that works with both its FreeStyle Libre 2 and FreeStyle Libre 3 CGM systems.

The medtech giant recalled FreeStyle Libre 3 sensors after the devices provided incorrect high glucose readings, with the US Food and Drug Administration (FDA) tagging the recall as Class I.

Medtronic announced today that it submitted 510(k) applications to the FDA seeking clearance for an interoperable insulin ...

Continuous glucose monitoring devices could overstate blood sugar levels, with a study revealing inconsistencies in readings compared with traditional methods.

Medtronic has secured a green light from the FDA to connect its latest automated insulin pump with its newest continuous ...

Glucose values in patients with type 1 diabetes (T1D) may vary based on the continuous glucose monitoring (CGM) system used ... arms from three CGM systems: FreeStyle Libre 3 (FL3; Abbott Diabetes ...

Maowasha say a Continuous Glucose Monitoring (CGM) device consists of a sensor and a transmitter. He says the transmitter can be connected to an individual phone which allows one to read numbers.

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

The Food and Drug Administration (FDA) has cleared the Dexcom G7 15 Day continuous glucose monitoring (CGM) system for ...

Science Connected Magazine is an editorially independent, non-profit newsroom producing open-access science journalism and ...

Apple's attempts to develop a non-invasive glucose monitoring feature for Apple Watch remains "many years away" from debuting ...

Blood glucose monitoring devices are essential tools for patients managing type ... report_id=bw8701 For instance, Abbott reported an increase in Freestyle Libre users from 4.5 million in 2022 to 5.0 ...